Output Explorer

[Page]
March Trimegestone Publication Management Meeting - Publication and Abstract Tracking Report
March 7, 2003, 8:30 AM-11:00 AM, Conference Room A3112 (Denmark)
II.
Manuscripts - Totelle 1mg Cycle
CONTA213-003866
Authors Priority |Article title
Stage
Journal Timing
Status
TBD
A
Paper PS(2)
Phase III TBD
Submit
First draft submitted for initial review August 9
A comparative 2-year study of the effects
March 2003 Comments received from Daniele December 7
of sequential regimens of 1 mg estradiol
Revised draft submitted January 13
and trimegestone with a regimen
Comments received from Richie February 28
containing estradiol and norethisterone
the patterns of endometrial bleeding
Waiting for comments from Daniele and Sophie
and safety in postmenopausal women
Needs major revisions because of inclusion of non-marketed
formulation
TBD
Paper PS(1)
Phase III TBD
Submit
First draft submitted for initial review August 8
A study of the control of climacteric
March 2003 Comments received from Daniele December 7
symptoms in postmenopausal women
Revised draft submitted January
following sequential regimens of 1mg
Comments received from Richie, February 28
estradiol and trimegestone compared with
a regimen containing estradiol and
Waiting for comments from Daniele and Sophie
norethisterone over a period of 2 years
Needs major revisions because of inclusion of non-marketed
formulation
TBD
B
Paper PS(3
Phase III TBD
Submit April First draft submitted for initial review April 19, 2002
Metabolic and hemostatic profile of
2003
Comments received from Gary M
postmenopausal women receiving a
Revised draft in preparation
combined sequential regimen of either
1mg estradiol and trimegestone or
According to Parthenon this is review at Wyeth, however Richie has
estradiol and norethisterone over a 1-year
not seen this recently.
period
TBD
B
Paper PS(3)
Phase III TBD
Submit April First draft submitted for initial review Apr 19
Metabolic and hemostatic profile of
2003
Comments received from Gary May 13
postmenopausal women receiving a
Revised draft to be submitted Dec 9
combined sequential regimen of either
Comments expected Jan 13
1mg estradiol and trimegestone or
Final paper to be submitted for review Feb 28
estradiol and norethisterone over a 1-year
Sign-off expected Apr 18
period
Source: https://www.industrydocuments.ucsf.edu/docs/sxvw0217
Confidential Pursuant to Confidentiality
Order

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.